These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2708377)

  • 1. Zymogen/enzyme discrimination using peptide chloromethyl ketones.
    Williams EB; Krishnaswamy S; Mann KG
    J Biol Chem; 1989 May; 264(13):7536-45. PubMed ID: 2708377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. II. Properties of thrombin derivatives as reporters of prothrombin fragment 2 binding and specificity of the labeling approach for other proteinases.
    Bock PE
    J Biol Chem; 1992 Jul; 267(21):14974-81. PubMed ID: 1634536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VII mutant V154G models a zymogen-like form of factor VIIa.
    Toso R; Bernardi F; Tidd T; Pinotti M; Camire RM; Marchetti G; High KA; Pollak ES
    Biochem J; 2003 Feb; 369(Pt 3):563-71. PubMed ID: 12358603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. I. Specificity of thrombin labeling.
    Bock PE
    J Biol Chem; 1992 Jul; 267(21):14963-73. PubMed ID: 1634535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active site-specific immunoassays.
    Mann KG; Williams EB; Krishnaswamy S; Church W; Giles A; Tracy RP
    Blood; 1990 Aug; 76(4):755-66. PubMed ID: 2116928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of activated factor X in the control of bovine coagulation factor VII.
    Morrison-Silverberg SA; Jesty J
    J Biol Chem; 1981 Feb; 256(4):1625-30. PubMed ID: 7462215
    [No Abstract]   [Full Text] [Related]  

  • 7. Active site-specific assays for enzymes of coagulation and fibrinolytic pathways.
    Tracy RP; Jenny R; Williams EB; Mann KG
    Methods Enzymol; 1993; 222():514-25. PubMed ID: 8412814
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of active site-inhibited factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin administration.
    Kjalke M; Oliver JA; Monroe DM; Hoffman M; Ezban M; Hedner U; Roberts HR
    Thromb Haemost; 1997 Oct; 78(4):1202-8. PubMed ID: 9364985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
    Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide chloromethyl ketones as labeling reagents.
    Williams EB; Mann KG
    Methods Enzymol; 1993; 222():503-13. PubMed ID: 8412812
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of thrombin by arginine-containing peptide chloromethyl ketones and bis chloromethyl ketone-albumin conjugates.
    Odake S; Kam CM; Powers JC
    J Enzyme Inhib; 1995; 9(1):17-27. PubMed ID: 8568563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, purification, and characterization of an Arg152----Glu site-directed mutant of recombinant human blood clotting factor VII.
    Wildgoose P; Berkner KL; Kisiel W
    Biochemistry; 1990 Apr; 29(13):3413-20. PubMed ID: 1970743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of subtilisin BPN' with peptide chloromethyl ketones.
    Powers JC; Lively MO; Tippett JT
    Biochim Biophys Acta; 1977 Jan; 480(1):246-61. PubMed ID: 831835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that meizothrombin is an intermediate product in the clotting of whole blood.
    Bovill EG; Tracy RP; Hayes TE; Jenny RJ; Bhushan FH; Mann KG
    Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):754-8. PubMed ID: 7773729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation factors VII and X induce Ca2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active.
    Camerer E; Rottingen JA; Iversen JG; Prydz H
    J Biol Chem; 1996 Nov; 271(46):29034-42. PubMed ID: 8910556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic properties of tripeptide lysyl chloromethyl ketone and lysyl p-nitroanilide derivatives towards trypsin-like serine proteinases.
    Collen D; Lijnen HR; De Cock F; Durieux JP; Loffet A
    Biochim Biophys Acta; 1980 Sep; 615(1):158-66. PubMed ID: 6448639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparent intrinsic prothrombinase activity of human Factor X zymogen: identification with Factor VIII inhibitor bypassing activity (FEIBA).
    Estry DW; Tishkoff GH
    Thromb Res; 1984 Dec; 36(6):549-62. PubMed ID: 6335607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotin derivatives of D-Phe-Pro-Arg-CH2Cl for active-site-specific labeling of thrombin and other serine proteinases.
    Anderson PJ; Bock PE
    Anal Biochem; 2001 Sep; 296(2):254-61. PubMed ID: 11554721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme.
    Lenting PJ; ter Maat H; Clijsters PP; Donath MJ; van Mourik JA; Mertens K
    J Biol Chem; 1995 Jun; 270(25):14884-90. PubMed ID: 7797466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity labeling of the catalytic subunit of cyclic AMP-dependent protein kinase by N alpha-tosyl-L-lysine chloromethyl ketone.
    Kupfer A; Gani V; Jiménez JS; Shaltiel S
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3073-7. PubMed ID: 226953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.